MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially nominated him to represent the company on the board, but appears to have changed its stance. In response to the shareholders’ concerns, the General Authority for Freezones and Investment restricted Hegazy from becoming a member on the board of any other companies, prompting him to step down from his position. October Pharma has not yet chosen who will replace the former chairman.
More from Enterprise
The CBE is taking a tougher stance on regulation
Last summer, HSBC paid the CBE a EGP 1.4 bn…
Farmers aren’t borrowing to survive anymore — they’re investing
Medium-term loans rose more than 1k% to EGP 22.6 bn…
The GCC IPO party took a breather in 2025
The region recorded 40 IPOs during the year, down from…
Valu gets regulatory green light to start operations in Jordan
Former Jordanian Investment Minister Mothanna Gharaibeh will serve as chairman…